ARTICLE | Company News
Salix balsalazide approvable letter
March 27, 2000 8:00 AM UTC
Salix (TSE:SLX) received an approvable letter from the FDA for its balsalazide disodium to treat mild-to-moderate ulcerative colitis. The product is marketed in the U.K. to treat acute ulcerative coli...